Invitrogen™ Peptide synthétique TM4SF1 humain
TM4SF1 Synthetic Peptide, PEP-1233, from Invitrogen.
- Gene ID (Entrez)
- 4071
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- P30408
- Nom usuel
- Human TM4SF1
- Marque
- Invitrogen
TM4SF1 Synthetic Peptide, PEP-1233, from Invitrogen.
TM4SF1 Synthetic Peptide, PEP-1233, from Invitrogen.
TM4SF1 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains and mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. TM4SF1 is a cell surface antigen and is highly expressed in the vascular endothelium of several human cancers. Knockdown experiments of TM4SF1 prevented filopodia formation, inhibited cell mobility, blocked cytokinesis, and inhibited maturation of VEGF-A-induced angiogenesis, suggesting that TM4SF1 may be an attractive target for anti-angiogenesis therapy.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15205239 |
| Caractéristiques | |
| Gene ID (Entrez) | 4071 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | P30408 |
| Nom usuel | Human TM4SF1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TM4SF1 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-1233 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 92 00 |